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Background: After a coma, patients with severe brain injury may present disorders of
consciousness (DOC). A substantial proportion of these patients also suffer from severe
dysphagia. Assessment of and therapy for swallowing disabilities of patients with DOC
are essential because dysphagia has major functional consequences and comorbidities.
Dysphagia evaluation in patients with DOC is impeded by the lack of adapted tools.
The first aim of this study was to create a new tool, the SWallowing Assessment
in Disorders Of Consciousness (SWADOC), and propose a validation protocol. The
SWADOC was developed to help therapists assess factors related to swallowing in
patients with DOC. The second aim was to investigate the relationship between patients’
level of consciousness and SWADOC items and scores.
Method/Design: In this multicenter prospective cohort, 104 patients with DOC will be
tested three times over five consecutive days with the SWADOC. Statistical analyses
will focus on the reliability and validity of the SWADOC, especially the intrarater and
interrater reliability, internal consistency, measures of dispersion, and concurrent validity
with the Facial Oral Tract Therapy Swallowing Assessment of Saliva (FOTT-SAS). The
level of consciousness will be assessed with the Simplified Evaluation of CONsciousness
Disorders (SECONDs) and the Coma Recovery Scale-Revised (CRS-R).
Discussion: The assessment of swallowing abilities among patients with DOC is the
first necessary step toward the development of a customized dysphagia care plan. A
validated scoring tool will be essential for clinicians to better assess dysphagia in patients
with DOC and document the evolution of their disorders.
Trial Registration: NCT04706689.
Keywords: swallowing, dysphagia, consciousness, severe brain injury, assessment
Mélotte et al. SWADOC Development and Validation
INTRODUCTION
After a coma, some patients with severe brain injury will develop
an altered state of consciousness before recovering partial or
complete consciousness. Disorders of consciousness (DOC)
consist of three states ranging from no awareness and no arousal
to the preservation of arousal with fluctuating awareness (1):
coma (2), vegetative state/unresponsive wakefulness syndrome
(UWS) (3, 4), and minimally conscious state (MCS) (5). Patients
with UWS typically exhibit only oromotor reflexes, blinks,
and startle responses, as well as withdrawal from noxious
stimuli (3). These patients do not respond to command and
do not show visual pursuit or fixation. Individuals with MCS
show reproducible but inconsistent signs of consciousness,
such as following commands, visual pursuit or fixation, and
localization of noxious stimuli (5). MCS has been subcategorized
into MCS PLUS (MCS+) and MINUS (MCS–) based on the
complexity of the observed responses: MCS+ describes high-
level behavioral responses (i.e., following commands, intelligible
verbalizations, intentional communication using a gestural or
verbal yes/no code), and MCS– describes low-level behavioral
responses (i.e., automatic motor behaviors, object manipulation,
localizing objects in space, localizing noxious stimuli, visual
pursuit or fixation) (6, 7). When patients recover the ability
to functionally communicate or to use objects appropriately,
we consider that they have emerged from MCS (EMCS)
(5). The currently recommended scale for the behavioral
assessment of consciousness is the Coma Recovery Scale–
Revised (CRS-R) (8), as it fulfills all the Aspen Neurobehavioral
Workgroup criteria (9). The CRS-R has an oromotor subscale
that includes the assessment of basic oromotor reflexes and
vocalizations or verbalizations, but no swallowing components
are integrated in this scale. Recently, the Simplified Evaluation
of CONsciousness Disorders (SECONDs) scale (10, 11) was
developed based on the most prevalent signs of consciousness
observed using the CRS-R (12). This tool is quick and
easy to administer (11).
Almost all patients with DOC have severe dysphagia
(13), requiring the use of ventilation and nutritional support
(i.e., tracheostomy, gastrostomy) to limit the occurrence
of comorbidities (e.g., bronchopulmonary infection,
undernutrition). Individuals with DOC classically receive
hydration and nutrition through an enteral feeding tube (14),
and a large majority will not be able to return to exclusively
oral feeding (13, 15). An objective swallowing assessment
using fiber-optic endoscopic or videofluoroscopic swallowing
evaluations is required in patients with DOC, for whom the
Abbreviations: CAMMRI, Comprehensive Assessment Measure for Minimally
Responsive Individuals; CRS-R, Coma Recovery Scale–Revised; DOC, Disorders
Of Consciousness; EMCS, Emergence from the Minimally Conscious State;
FILS, Food Intake LEVEL Scale; FOTT, Facial Oral Tract Therapy; FOTT-SAS,
Facial Oral Tract Therapy Swallowing Assessment of Saliva; IDDSI, International
Dysphagia Diet Standardization Initiative; MCS, Minimally Conscious State;
NZSS, New Zealand Secretions Scale; SECONDs, Simplified Evaluation of
CONsciousness Disorders; SWADOC, SWallowing Assessment in Disorders Of
Consciousness; UWS, Unresponsive Wakefulness Syndrome.
possibility of partial or total oral feeding is being considered.
These examinations, performed by experienced clinicians,
constitute the gold standard tool for assessing dysphagia in
this population. Indeed, these examinations allow clinicians to
precisely analyze the mechanisms at play during swallowing and
to detect possible silent aspirations, which are very prevalent
in patients with DOC (13). As Mélotte et al. (13) showed in a
cohort of 92 patients, the risk of silent aspiration is high for these
patients, as 48% of DOC patients do not have a cough reflex.
Moreover, 28% presented saliva aspiration, 13% aspiration with
thick texture, and 32% aspiration with liquid texture. A lack
of knowledge of the specific features of DOC prevents some
clinicians from performing these exams. Moreover, performing a
functional swallowing test (liquid and food test) can be difficult
in patients with severe trismus (lockjaw) or total absence of the
oral phase of swallowing, but as long as a partial oral phase with
initiation of swallowing exists, thick or liquid swallowing can be
tested (13, 16–18).
In daily practice, speech therapists help document the
presence or absence of a range of components required
for swallowing in order to guide therapy and monitor its
effectiveness by repeated assessment over time. The clinical
reality of patients with DOC, mainly the lack of response to
simple motor commands (in UWS and MCS–) and functional
communication, makes it difficult to fully understand and
appropriately treat their swallowing disorders. For these reasons,
classical swallowing assessment at the bedside can be unsuitable
for this population. There is a lack of appropriate bedside tools
to appraise and monitor swallowing disorders in patients with
DOC. The impossibility of orienting interventions based on
determined quantitative and qualitative swallowing components
makes it more difficult to develop a treatment plan and assess the
patient’s progress.
Our recent DOC cohort study (13) found some links between
swallowing and the level of consciousness. In particular, none of
the patients with UWS and only a minority of the patients in
MCS exhibited an effective oral phase of swallowing (adequate
lip prehension, tongue propulsion, and no post-swallowing oral
stasis). However, these links are not yet completely understood,
and further studies are necessary to increase our knowledge of
which components of swallowing are linked to consciousness
and to what extent. In this context, the validation of a tool that
focuses on qualitative and quantitative swallowing components
will help us identify swallowing behaviors that may be considered
unequivocal signs of consciousness in patients with DOC. These
results may eventually contribute to the development of new
diagnostic guidelines for DOC that would include swallowing
behaviors in their criteria.
The aim of this article is to present a protocol that
develops and validates the SWallowing Assessment in
Disorders Of Consciousness (SWADOC). This tool will
be administered repeatedly to a population of patients
with DOC by different examiners, and intrinsic test
characteristics will be calculated. The relationship between
patients’ level of consciousness and SWADOC scores will also
be studied.
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METHODS AND ANALYSIS
Development of the Swallowing
Assessment in Disorders of
Consciousness
Identification of Domain(s) and Item Generation
The SWADOC was developed to overcome the lack of a
suitable tool that would allow clinicians to assess and measure
swallowing-related components in patients withDOC. It explores
some of the oral and pharyngeal components of swallowing
as well as a range of prerequisites and related components
of swallowing. Our first aim was to develop a rapid, reliable
quantitative tool. However, although quantitative items present
advantages, many qualitative elements are also meaningful in
fully understanding a patient’s profile. Thus, we decided to
include both quantitative and qualitative items.
This tool was developed by three speech therapists and then
submitted for evaluation to 10 experts (otorhinolaryngologists
and speech therapists) who work with patients with DOC. Their
comments contributed to the final version. The development
period lasted∼10 months.
The tool was developed based on both deductive and inductive
methods (19). First, we examined literature in the field of
consciousness and swallowing, and looked for existing scales
(deductive method). The construction of the tool was inspired by
actual knowledge on dysphagia in DOC patients based on the few
studies dedicated to swallowing in DOC patients (13, 15, 18, 20).
The SWADOC was built based upon several existing
tools: the Facial Oral Tract Therapy (FOTT) (21, 22), the
SECONDs (10, 11), the New Zealand Secretions Scale (NZSS)
(23), the Oral/Facial Sensitivity subtest of the Comprehensive
Assessment Measure for Minimally Responsive Individuals
(CAMMRI) (24), the stimulation method for sensory processing
disorder (sensory dysorality) proposed by Senez (25), and the
arousal protocol of the CRS-R (8). It includes some medical
history information from the Food Intake LEVEL Scale (FILS)
(26) and the International Dysphagia Diet Standardization
Initiative (IDDSI) (27).
The SWADOC was inspired by the FOTT (22), as adapted
for patients with DOC in French by Bicego et al. (21), and
modified based on our day-to-day clinical experience with
patients with DOC. The items assessing command following
are based on the SECONDs principles (10, 11), insofar as
response to verbal command is considered intact if the patient
passes a minimum of two out of three trials. The item on
quantitative saliva secretions is based on the NZSS (21), which
assesses secretion severity during endoscopy by location, amount
(as a percentage), and response. We used the percentages
proposed in that scale and adapted them to the oral cavity.
Since the oral area is larger than the laryngeal area, the
percentages are more difficult to evaluate, but to our knowledge,
there is no validated scale for the evaluation of accumulated
secretions in the mouth. Tactile stimulation is inspired by
Senez’s stimulation method for sensory processing disorder
(25). Finally, the SWADOC requires the examiner to perform
an arousal protocol similar to the CRS-R (8) if the patient
falls asleep during the procedure. The medical history taking
subsection also features the IDDSI (27) score and the FILS
(26) score.
We then applied the tool in routine clinical practice with
patients with different levels of consciousness and adjusted some
items as a result (inductive method).
Content Validity
Ten experts were asked to judge the SWADOC overall and
per item with a Likert scale to solicit their opinion of its
relevance in their clinical practice, its suitability for patients
with DOC, and the clarity of the administration guidelines. The
experts’ responses focused on the clarity of certain instructions
and suggested that some qualitative items be added and some
quantitative items modified (levels that were too subjective
or dependent on hospital functioning and not on patients
themselves). These suggestions were analyzed and taken into
account to improve the SWADOC by clarifying instructions,
adding qualitative items, and modifying quantitative items.
Presentation of the Tool
The tool is composed of 56 items: 48 qualitative items and
a subsection called the “SWADOC-scored” comprising eight
quantitative items. The instruction guide comprises (1) one page
with general recommendations; (2) a list of required materials;
(3) explanations of the quantitative items; (4) a detailed medical
history; (5) the SWADOC-scored grid; and (6) a checklist and
seven pages of instructions covering all the quantitative and
qualitative items (Figure 1; Supplementary Materials 1, 2). The
tool was translated into English for the convenience of readers
of this paper. However, if an English validation is carried out, a
back-translation method will be applied.
The “SWADOC-scored” subsection includes eight
quantitative items (Figure 2; Supplementary Material 3).
Four items are linked to the oral phase and four to the
pharyngeal phase. For each quantitative item, patient’s abilities
are rated on a four-level scale ranging from 0 to 3. These levels
correspond to item scores that can be added together to calculate
three performance scores: the oral phase subscore (sum of the
four oral item scores), the pharyngeal phase subscore (sum of
the four pharyngeal item scores), and the total swallowing score
(sum of the eight item scores).
The administration procedure for the test and the sequencing
of items were designed to put patients in optimal conditions
for the exam. For example, the therapist first introduces
himself/herself, describes the assessment procedure, and then
begins with external facial stimulation before doing the mouth
cavity stimulation. The therapist assesses the patient at the
bedside or in his or her usual chair and only if the patient is
awake and shows no signs of pain or medical problem (e.g., fever,
hypoxemia, and arrhythmia). In addition, during the assessment,
some parameters for stopping are provided to avoid presenting
stimulations that are inappropriate for the patient’s abilities (e.g.,
swallowing a minimal amount of thickened liquid). All these
recommendations are described in the administration guide.
The objectives of the SWADOC are to address all of the
goals of an assessment tool: (1) document the prerequisites for
swallowing; (2) determine the active ingredients of the therapy;
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FIGURE 1 | Description of the SWADOC. ENT, Ear, Nose, and Throat; SWADOC, SWallowing Assessment in Disorders Of Consciousness.
FIGURE 2 | SWADOC-scored (English version). DOC, disorders of consciousness; SWADOC, SWallowing Assessment in Disorders Of Consciousness.
(3) track changes in a patient’s swallowing abilities; and (4)
monitor the effectiveness of a therapy. In a scientific research
context, the SWADOC will help us better understand the links
between the level of consciousness and swallowing components.
Study Design
This project is a multicenter prospective cohort study that will
take place in several hospitals and clinics in Belgium and France.
The SWADOC was created in French.
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Population and Recruitment
This study will be carried out in patients with DOC or emerging
from DOC following severe acquired brain injury. Patients will
be divided into four groups according to their clinical diagnosis,
as assessed with the SECONDs and with the CRS-R: UWS,
MCS–, MCS+, and EMCS. Participants will be recruited from
inpatient neurological rehabilitation programs in post-coma
units and rehabilitation services or among patients hospitalized
for a multimodal assessment of consciousness for diagnostic and
prognostic purposes.
Only patients who meet all of the following inclusion criteria
will be considered for enrollment: (1) age above 18 years; (2)
perfect knowledge of French language before the injury; (3)
previous coma phase caused by a severe acquired brain injury;
(4) medical stability (no mechanical ventilation or sedation, no
acute medical pathology such as infection or respiratory distress);
(5) no neurological or otorhinolaryngological disease that can
impact swallowing prior to the brain injury; (6) minimum
of 28 days since the acquired brain injury at inclusion (28,
29); (7) diagnosis of UWS, MCS–, MCS+, or EMCS based
on the SECONDs and the CRS-R; (8) informed consent from
the patient’s legal representative; and (9) affiliated patient or
beneficiary of a health insurance plan (for participants in
France only).
Validation of the Study Procedure
Each patient enrolled in the validation study will have his or
her level of consciousness assessed at baseline with a single
administration of the CRS-R. Next, the level of consciousness
and swallowing abilities will be assessed with three tools during
three separate sessions (only one administration of the FOTT-
SAS) in the morning or the afternoon in order to assess the tool’s
intrarater and interrater reliability. The baseline assessment and
sessions will be spread over 5 consecutive days.
1. CRS-R: This is a standardized neurobehavioral assessment
of consciousness composed of six subscales (auditory, visual,
motor, oromotor/verbal, communication, and arousal).
It assesses different functions with various numbers of
hierarchically arranged items that distinguish UWS, MCS,
and EMCS patients. The total score is composed of the sum
of the maximum scores obtained in each subscale.
2. SECONDs: It is shorter to administer (median of 7min) and
requires only a mirror as material. It consists of eight items:
observation and reporting of spontaneous behaviors, response
to command, communication, visual pursuit and fixation,
pain localization, oriented behaviors, and arousal. We have
chosen this consciousness tool during sessions rather than the
CRS-R because of its short duration so that the SWADOC
can be administered immediately before or after, given that
attentional abilities are often reduced in patients with DOC.
The SECONDs provides a total score directly reflecting one
diagnosis (0 = coma; 1 = UWS; 2–5 =MCS–; 6–7 =MCS+;
8= EMCS).
3. SWADOC: This tool includes a battery of 56 quantitative
and qualitative items. Quantitative items are grouped in the
SWADOC-scored, with oral and pharyngeal subscores and a
total score. Running the whole SWADOC lasts between 15
and 25min based on preliminary tests.
4. FOTT-SAS: The results of the SWADOC-scored in one
session will be compared to those of the FOTT Swallowing
Assessment of Saliva (FOTT-SAS) (30). The test comprises
seven questions; if items 1–4 are answered “Yes” and items
5–7 are answered “No,” oral intake should be initiated
(Supplementary Material 4). The FOTT-SAS includes items
that can be scored based on the administration of the
SWADOC. In that respect, no additional administration will
be required.
The clinical protocol procedure is illustrated in Figure 3.
Because of clinical realities, no attempt will be made
beforehand to standardize the order (SECONDs before or after
SWADOC and examiner 2 before or after examiner 1) or time of
day (morning or afternoon) of evaluations. However, during data
collection, efforts will progressively be made to balance the order
and time of day and the time of evaluation of examiner 2 (before
or after examiner 1).
The administration of the SWADOC at each session will
allow us to assess the tool’s intrarater reliability (temporal
stability). Directly before or after one of the three sessions, a
second examiner will administer the SWADOC a second time
to test its interrater reliability. The second assessment will be
blinded to the results of the first. To be able to take into
account potential mismatches between the ratings of the two
examiners, each scoring protocol will be analyzed directly after
the interrater session and a discussion will follow to try to
understand the reasons for any discrepancies. This information
will be noted in the protocol. After the recruitment procedure
and depending on the degree of agreement based on the statistical
analysis, modifications of the instructions, and/or items will be
considered based on the qualitative information collected from
the examiners.
Sensitivity to change will determine whether changes in the
level of consciousness (variations in SECONDs scores) result in
changes in the SWADOC-scored across the three assessments
of the same patient. Repeating the SECONDs assessment will
also allow for a reliable assessment of the patient’s level of
consciousness (UWS, MCS–, MCS+, or EMCS) and decrease the
risk of misdiagnosis (31).
Study Hypotheses
Our main hypothesis is that the SWADOC is reliable and valid.
Our second hypothesis is that the subscores (oral phase and
pharyngeal phase) and the total score are related to the patient’s
level of consciousness. Moreover, based on previous studies
(13, 15), we expect that UWS patients will be at level 0 for
oral phase items 1, 3, and 4 of the SWADOC-scored: no mouth
opening at spoon approach, no spontaneous lip prehension, and
no appropriate tongue propulsion.
Data Analysis
The statistical significance will be set at p < 0.05.
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FIGURE 3 | Study protocol. Example of the assessment program for a patient. The program for each patient is organized such that the three sessions take place over
5 days in the morning or in the afternoon. The SECONDs is administered before or after the SWADOC. Examiner 2 will administer the SWADOC before or after
examiner 1 in one of the three sessions. Examiner 1 will score the FOTT-SAS after one of the three sessions. SECONDs, Simplified Evaluation of CONsciousness
Disorders; SWADOC, SWallowing Assessment in Disorders Of Consciousness; FOTT-SAS, Facial Oral Tract Therapy Swallowing Assessment of Saliva.
Power of the Study
The sample size was calculated using a power calculation (G ∗
Power, Universities of Kiel, Mannheim, andDüsseldorf) in a one-
way analysis of variance (ANOVA) with a significance level of
0.05 and a power of 0.8. Effect size is based on previous published
data on swallowing performance in patients with DOC (13).
Cohen’s d was used to estimate the effect size; the result was
0.659, corresponding to an eta-squared of 0.0979. We round up
and base our calculation on an effect size of 0.1, corresponding
to an intermediate effect. In this context, a total sample size
of 104 participants (26 per group) is needed to demonstrate a
difference in SWADOC‘ subscores and total score between the
four consciousness groups. If, by the end of June 2025 the sample
size is not reached, we will discuss extending the data collection
period if necessary.
Descriptive Analysis
First, descriptive statistics will be performed to describe the entire
group and each diagnostic group (UWS, MCS–, MCS+, and
EMCS) for age, gender, etiology, and time since insult. To test
gender independence between groups, we will use chi-square
tests. For the other variables, we will perform a one-way ANOVA
with group as an independent variable. Homogeneity of variance
will be assessed using Levene’s test. In case of violation, we will
use Welch’s approximation of a ANOVA.
Reliability
The intrarater (i.e., SWADOC-scored vs. SWADOC-scored by
the same examiner on the same day and on two different days)
and interrater reliability (i.e., SWADOC-scored vs. SWADOC-
scored on the same day by two different examiners) will be
calculated in two separate analyses using weighted Fleiss’s kappa
coefficients (KW). A value below 0 will be considered to indicate
poor agreement, between 0 and 0.2 slight agreement, between
0.21 and 0.4 fair agreement, between 0.41 and 0.6 moderate
agreement, between 0.61 and 0.8 substantial agreement, and
between 0.81 and 1 almost perfect to perfect agreement (32). We
will also determine the internal consistency of the SWADOC-
scored with Cronbach and Spearman intercorrelations to
determine the interrelatedness of the constituent items.
Validity
Concurrent Validity
The results of the SWADOC-scored will be compared to
the FOTT-SAS score for the same time and with the best
score using Pearson’s correlation (parametric test) or Kendall’s
correlations (nonparametric test) after examination of the
data distributions.
Measures of Dispersion
The distribution of total SWADOC-scored scores will be
examined to determine whether performance on the scale is
evenly distributed across the range of possible scores, and each
item will be analyzed to identify possible floor or ceiling effects.
Based on these results, we will consider the need to modify the
scale accordingly.
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Relationship Between Swallowing Components and
Levels of Consciousness
The differences in SWADOC-scored items, oral and pharyngeal
subscores for the SWADOC-scored, and total score for the
SWADOC-scored for the consciousness diagnostic groups will be
assessed using a comparison of means with a one-way ANOVA.
Violation of the homogeneity of variance will be checked using
Levene’s test. If this is the case, we will useWelch’s approximation
instead of an ANOVA. If there is a significant main effect,
we will perform Tukey’s honestly significant difference (HSD)
test to compare all pairwise differences. If there is a severe
violation of the normality, we will perform a Kruskal–Wallis
test with the Dwass-Steel-Critchlow-Fligner (DSCF) multiple
comparison analysis. Partial eta-squared will be used as ameasure
of effect size. Post-hoc multiple comparisons will be conducted
to identify where significant differences between consciousness
groups exist. SWADOC scores will be the dependent variable,
while consciousness group will be the independent variable.
Statistical analysis will be performed by a researcher blind to the
consciousness category.
DISCUSSION
It is challenging to assess swallowing in patients with DOC
because of the clinical reality of this population. This protocol
describes a clinical study that will seek to validate the SWADOC,
a tool adapted for bedside swallowing assessments in patients
with DOC. The link between patients’ level of consciousness and
SWADOC scores will also be studied. To achieve these goals, a
multicenter prospective cohort study design will be adopted.
Strengths and Opportunities
To our knowledge, this is the only published study protocol
that seeks to validate a swallowing assessment tool for patients
with DOC. To meet all the criteria for an optimal assessment
tool (i.e., appraise patients’ abilities, monitor their progress,
measure the effect of a given therapy, allow comparison with
other patients), the SWADOC is composed of both quantitative
and qualitative items.
The quantitative items will help measure any changes and
treatment effects, while the qualitative items will help clinicians
provide a clear and accurate summary of the patient’s strengths
and weaknesses, and thus orient his or her therapy in the best
possible way. Depending on the treatment plan, the dysphagia
therapy may be oriented more toward active stimulation to
improve salivary control and efficiency of the oral and pharyngeal
phases or toward maximizing the patient’s comfort.
In a second phase, it would be interesting to compare the
results of the SWADOC with an objective assessment (fiber-
optic endoscopic evaluation of swallowing or videofluoroscopic
swallowing study) to determine its predictive validity and
investigate its construct validity. However, the SWADOC is not
intended to be the only tool used to determine the possibility
of reintroducing oral nutrition for the patient: we acknowledge
the need to objectively evaluate patients with DOC before
reintroducing oral feeding, as the risk of inhalations and silent
aspirations is very high. The SWADOC will complement the
therapeutic framework for dysphagia among patients with DOC
in order to set up the active components of therapy (33),
measure the efficacy of the therapy, and orient therapists toward
an objective examination when the patient’s recovery seems to
allow it.
Limitations and Pitfalls
There are a number of limitations on this study especially because
of the clinical challenges of dealing with patients with DOC. The
main limitation is the feasibility of having each patient undergo
a baseline administration of the CRS-R and three assessments.
This group’s arousal fluctuates considerably, as they are highly
sensitive to stress and fatigue, and often subject to medical
complications (e.g., vomiting, pain, respiratory infections, etc.)
that may limit their availability to participate in the study. To take
into account this pitfall of the application of the methodology to
patients with DOC, we chose to extend the evaluation period to
five days rather than two days as initially planned.
Although, we have developed the most accurate levels possible
for each item and a complete scoring guide, the SWADOC is
based on subjective observations of swallowing components. The
interrater reliability will help us determine the consistency of the
rating system between examiners. Depending on these results, the
scale may be adapted.
Furthermore, the decision to assess the level of consciousness
using the SECONDs may seem questionable because this scale
is recent, but it is derived from the CRS-R, which is known
to be the gold standard scale for behavioral assessment of
consciousness. Nevertheless, the SECONDs is much quicker to
administer and includes the five CRS-R items that detect 99% of
MCS patients (12). Moreover, this scale has good intra- and inter-
rater reliability (kappas ranging from 0.85 to 0.91 and 0.82 to 0.85,
respectively). However, we considered adding one administration
of the CRS-R at baseline before the three sessions because the
CRS-R gives more details and precision on the patient’s overall
state, including reflexes.
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